[1-11C]Acetate uptake is not increased in renal cell carcinoma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 6, 2007, Pages 884-888

  Kotzerke, J ^a   Linne C ^a   Meinhardt, M ^a   Steinbach, J ^b   Wirth, M ^a   Baretton, G ^a   Abolmaali, N ^c   Beuthien Baumann, B ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

1 11C acetate; Kidney tumour; Positron emission tomography

Indexed keywords

ACETIC ACID C 11; TRACER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR LOCALIZATION;

ACETATES; ADULT; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 34249095468     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0362-5     Document Type: Article

References (12)

1. Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-92.
2. 11C-acetate whole-body PET. J Nucl Med 2004;45:1233-6.
3. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003;44:213-21.
4. 11C-acetate clearance in nasopharyngeal carcinoma. Nucl Med Commun 1999;20:131-4.
5. 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2004;31:13-21.
6. Shreve P, Chiao PC, Humes HD, Schwaiger M, Gross MD. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995;36:1595-601.
7. Kotzerke J, Volkmer BG, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2002;29:1380-4.
8. Thoenes W, Storkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-43.
9. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:987-9.
10. 11C acetate positron emission tomography: case report and literature review. Mol Imaging Biol 2006;8:208-11.
11. 18F-FDG PET. AJR Am J Roentgenol 2006;186:269-70.
12. Bachor R, Kotzerke J, Gottfried HW, Brandle E, Reske SN, Hautmann R. Positron emission tomography in diagnosis of renal cell carcinoma. Urologe A 1996;35:146-50.